Anthony Walsh is a seasoned professional in the biotechnology and investment sectors, currently serving as a Strategic Advisor at Reverb Therapeutics and the Chief Executive Officer at Synkentro Therapeutics. With previous experience as a Partner at Mission BioCapital and as Managing Director at LYFE Capital, Anthony has demonstrated expertise in leadership and strategy development. Prior roles include an Associate position at RA Capital Management, LLC, and an Executive in Residence role at Formation Bio. Anthony holds a Doctor of Philosophy (Ph.D.) in Biophysics and Molecular Biology from the University of Oxford and has completed postdoctoral research at Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices